____________________________________________________________________________________

Monday, August 25th

“You never know what worse luck your bad luck has saved you from.”

– Cormac McCarthy

____________________________________________________________________________________

Back by popular demand — Alex’s State of the Market Report!

____________________________________________________________________________________

Major Market Events 

• US stock futures slide — Markets pause after record surge; Nvidia earnings in focus
• Tech Rally Losing Steam? — Investors are starting to doubt valuations of high flyers like Nvidia
• US–EU trade talks hit rough waters — Negotiations continue with warnings over key disagreements

____________________________________________________________________________________

🤔 My Thoughts

Why I Bought MBOT Live (Shares + Calls)

Shares + long-dated calls on a patent-backed micro-cap

A tiny robotics play with real IP — sized small, risk first

I don’t buy every headline. I buy what I can explain.

On Friday’s Profit Panel,I put real money into Microbot Medical (MBOT) — both shares and a small lot of long-dated calls — while we were on air.

What I did (exactly)

• I said it on the show: “Alright, so… so, buying shares, I bought 100 shares of Microbot Medical.”
• Then I added calls: “MBOT. 16 January, 25… Two and a half dollar calls…”
• And I logged the fill so it’s clear: “I got in on $1.45 on the calls.” 

Why this name?

Simple: intellectual property plus a focused use case in surgical robotics. On the call I laid out the catalyst stack:

• “they just got a patent for this Liberty… Liberty Endovascular robotic System.” 
• “12 granted patents, 57 pending applications.” 

Think of MBOT as a micro-cap robotics bet with a real patent trail.

If you’ve looked at Intuitive Surgical and thought, “great company, too rich for me,” you’ll get why a tiny name with fresh IP can catch my eye: “Intuitive Surgical, right, is really expensive.” I’m not comparing revenues — I’m comparing direction of travel: specialized robotics solving precise problems.

Why shares and calls?

• Shares give me a base I can hold through normal noise
• Long-dated, cheap calls give me asymmetric upside if the story catches — with the premium I paid being my max risk

How I’m managing it

• Size stays small. This is a micro-cap; it can gap.
• I’ll scale, not chase. If it proves itself, I can add in small plays along the way. If it breaks down or the thesis changes, I’m out — no debate.
• I’ll take base hits. If the calls pop on a news burst, I’ll trim. If shares grind higher, I’ll let time work.

Risks (read this twice)

Micro-caps are volatile. Liquidity can vanish. Patents are not sales. That’s why position size and exits matter more than the story.

The bottom line:

I bought MBOT because I can point to what they own (patents) and what they’re building (Liberty endovascular robotic system), and I sized it so a bad day is just a paper cut.

Shares for foundation, long-dated calls for optionality. Simple, controlled, repeatable.

Click here to watch the on-demand replay!

And don’t forget to register your spot here to join us next time we go live!

To Better Trading,

Alex Reid

____________________________________________________________________________________